Ann: Encouraging SRC Findings on Ph I/II Skin Cancer Trial, page-6

  1. 5 Posts.
    lightbulb Created with Sketch. 5
    Could be an optics issue ie, little people know about it. These initial results are promising
    No pain and significant reduction in size after only one treatment
    There is definitely a patient comfort issue with other treatments at the moment. Some disturbing stories about Metvix come to mind

    @Warren1974 It is a great announcement, with plenty of room to grow in the adaptive trial format


 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
9.6¢
Change
0.000(0.00%)
Mkt cap ! $8.199M
Open High Low Value Volume
9.6¢ 9.8¢ 9.6¢ $3.656K 38.07K

Buyers (Bids)

No. Vol. Price($)
2 20756 9.6¢
 

Sellers (Offers)

Price($) Vol. No.
9.9¢ 146502 2
View Market Depth
Last trade - 15.11pm 07/08/2025 (20 minute delay) ?
IVX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.